1. The FDA approved a next generation version of Abbott’s MitraClip heart valve repair device, which offers an alternative to open-heart surgery.
2. Medtronic’s HeartWare HVAD System is now the only left ventricular assist device approved for implantation via a thoracotomy.
3. A combination of Bristol-Myers Squibb’s cancer drugs Opdivo and Yervoy may now be used to treat a specific form of metastatic colorectal cancer.
More articles on supply chain:
Analysis: FDA advisory committees filled with ‘pay-later conflicts of interest’
3 tips to utilize the Internet of Things (IoT) in the healthcare supply chain
A simpler solution for direct manufacturer shipments: 5 Qs with Cardinal Health’s director of supply chain solutions
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.